| Document |
Document Title |
|
WO/2022/017975A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and t...
|
|
WO/2022/020714A1 |
Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such...
|
|
WO/2022/017531A1 |
The present invention relates to a compound for treating thrombotic diseases. Specifically, the present invention provides a compound represented by formula I, or a pharmaceutically acceptable salt, or an enantiomer, or a diastereoisomer...
|
|
WO/2022/016898A1 |
The present application provides an organic compound, an organic electroluminescence device and an electronic apparatus. The chemical structure of the organic compound in the present application comprises an adamantane spirofluorene ring...
|
|
WO/2022/017997A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2022/013417A1 |
Compounds of the formula (I), wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and ...
|
|
WO/2022/013378A1 |
The present invention relates to compounds of general formula (I) inhibiting lysophosphatidic acid receptor 1 (LPA1), particularly the invention relates to compounds that are Ami do cyclohexane acid derivatives, methods of preparing such...
|
|
WO/2022/007909A1 |
The present application relates to the technical field of organic material and provides a nitrogen-containing compound, an electronic component and an electronic device. The nitrogen-containing compound has a structure as shown in formul...
|
|
WO/2022/010537A1 |
Provided herein are small molecules that bind to GAS41 and inhibit GAS41 activity, and methods of use thereof for the treatment of cancer.
|
|
WO/2022/002077A1 |
Disclosed in the present invention are an aryl aromatic heterocyclic derivative and preparation thereof and use thereof. The structure is as shown in formula I, and in this formula, the definitions of substituents are as stated in the de...
|
|
WO/2022/004473A1 |
The present invention provides: a photoelectric conversion element which has excellent photoelectric conversion efficiency with respect to blue to green light (specifically, light having a wavelength of from 400 nm to 550 nm), and which ...
|
|
WO/2021/261447A1 |
The present invention addresses a first problem of providing a photoelectric conversion element having high external quantum efficiency and little response variation. The present invention also addresses a second problem of providing an ...
|
|
WO/2021/259798A1 |
The present invention relates to a chemical compound having the general formula (I): wherein R1 is a phenyl group or a substituted phenyl group, R2 is a meta-substituted phenyl group and RTA is a substituted or unsubstituted thiophene ri...
|
|
WO/2021/249337A1 |
Disclosed in the present invention is a series of dimethylsulfoximine derivatives, and specifically disclosed are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
|
|
WO/2021/238622A1 |
Disclosed in the present invention are a compound and an application thereof. The compound of the present invention has the structure shown in formula (1). The compound obtained in the present invention by connecting phenanthrene and flu...
|
|
WO/2021/241900A1 |
The present specification relates to a compound of chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2021/234551A1 |
A small crystal size, high surface area aluminogermanosilicate molecular sieve material, designated SSZ-120, is provided. SSZ-120 can be synthesized using 3,3'-[2,6-naphthalenebis(methylene)]bis[1,2-dimethyl-1H-imid
azolium] dications as...
|
|
WO/2021/230513A1 |
Provided is an organic compound contributing to improving the substantial light efficiency and field of view of an organic electroluminescent device. The organic electroluminescent device according to the present invention comprises: a f...
|
|
WO/2021/230653A1 |
The present invention relates to: an anthracene derivative compound having a specific structure; and an organic light-emitting device having low-voltage driving characteristics, comprising same, and also relates to an organic light-emitt...
|
|
WO/2021/227655A1 |
Provided are a compound, an organic electroluminescent device, and a display device. The compound has a structure as shown in formula I. The introduction of the substituent Ar2 at position 1 on a naphthalene ring can not only adjust the ...
|
|
WO/2021/226675A1 |
The invention provides a zwitterionic plastic crystal (ZIPC) compound in the form of a single molecule comprising: at least one positively charged functional group carrying at least one positive charge, and at least one negatively functi...
|
|
WO/2021/224102A1 |
Compounds of the formula (I), wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.
|
|
WO/2021/219775A1 |
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.
|
|
WO/2021/218588A1 |
The present application belongs to the field of organic light-emitting materials, and specifically relates to a nitrogen-containing compound, an electronic component using same and an electronic device. The nitrogen-containing compound h...
|
|
WO/2021/221108A1 |
The present invention provides: a photoelectric conversion element having excellent sensitivity; an imaging element, an optical sensor; and a compound. This photoelectric conversion element comprises, in the given order, an electroconduc...
|
|
WO/2021/218491A1 |
Provided are a nitrogen-containing compound, an electronic element, and an electronic device, and the present application belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown ...
|
|
WO/2021/214117A1 |
The invention relates to kinase inhibitors, in particular inhibitors of protein kinases including the SIK-family CSF1R, ABL/BCR-ABL, SRC, HCK, PDGFR, KIT and/or their mutants. Although structurally similar to dasatinib, the kinase inhibi...
|
|
WO/2021/213109A1 |
The present application belongs to the field of organic materials, and relates to an arylamine compound, an electronic component using same and an electronic device. The arylamine compound has the structure as shown in formula 1. The ary...
|
|
WO/2021/210774A1 |
The present invention provides a novel compound and an organic light-emitting element comprising same.
|
|
WO/2021/210305A1 |
An organic electroluminescent element (1) comprises: a negative electrode (3); a positive electrode (4); a first light-emitting layer (51) disposed between the negative electrode (3) and the positive electrode (4) and containing a first ...
|
|
WO/2021/208951A1 |
Disclosed is a β-diketone cerium (IV) compound of formula (I). The compound has a wide absorption band, is suitable for near ultraviolet-visible region curing as a photoinitiator, and has a high sensitiveness, while also having the adva...
|
|
WO/2021/207469A1 |
Embodiments of the present disclosure pertain to compositions that include a compound that inhibits the histone acetyl transferase activity of a protein, such as p300 and/or CBP. Further embodiments of the present disclosure pertain to m...
|
|
WO/2021/206488A1 |
The present invention relates to an anthracene compound represented by [Formula A] and an organic light-emitting element comprising same, wherein [Formula A] is as described in the detailed description of the invention.
|
|
WO/2021/197889A1 |
The present invention relates to a new process for the production of new specific intermediates, which are preferably used in the production of vitamin A, vitamin A acetate, or β-carotene and derivatives thereof, e.g. canthaxanthin, ast...
|
|
WO/2021/200179A1 |
The present invention provides an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which increases in polarity by the action of an acid and (B) a compound which generates an acid upon irradiation with...
|
|
WO/2021/201449A1 |
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device comprising the organic electronic element. According to the present invention, an organic e...
|
|
WO/2021/200178A1 |
The present invention provides: an actinic ray-sensitive or radiation-sensitive resin composition containing (A) a resin in which polarity is increased due to acid activity, and (B) a compound which is represented by a specific general f...
|
|
WO/2021/197890A1 |
The present invention relates to a new process for the production of vitamin A and/or its derivatives.
|
|
WO/2021/193654A1 |
Provided are a compound that further improves the performance of an organic EL element, an organic electroluminescent element having improved element performance, and an electronic device including such an organic electroluminescent elem...
|
|
WO/2021/183830A1 |
A method of treating a patient suffering from disease that is caused by organ/tissue fibrosis includes the administration of a PKM2 activator. The PKM2 activator can reduce LOX protein expression and activate PKM2.
|
|
WO/2021/175971A1 |
Disclosed are TRPM8 modulators as defined by formula (I) for achieving a cooling effect on skin and mucosa.
|
|
WO/2021/177290A1 |
A method for producing a mono-cross-coupled aromatic compound (3-1), said method comprising: preparation of an aromatic compound (1) that has at least two leaving groups; preparation of a compound (2) that is capable of undergoing a cros...
|
|
WO/2021/163921A1 |
Provided is a compound, which has an excellent chemical stability, a high solubility to a solvent, and exhibits an excellent carrier mobility. The compound is a compound represented by the following formula (1). [In formula (1), X1, X2, ...
|
|
WO/2021/167008A1 |
This method for producing an aromatic astatine compound comprises reacting aromatic iodonium ylide with astatine to produce an aromatic astatine compound.
|
|
WO/2021/164572A1 |
The present application relates to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element, and an electronic device. The structure of the nitrogen-containing compound is as represente...
|
|
WO/2021/161887A1 |
[Problem] To provide a novel compound which has high absorption selectivity for the long-wavelength ultraviolet to near ultraviolet region close to a wavelength of 400 nm, exhibits high weathering resistance, and has a merocyanine skelet...
|
|
WO/2021/162384A1 |
The present invention provides a novel compound capable of improving the luminous efficiency, stability, and lifespan of a device, an organic electric device using same, and an electronic device thereof.
|
|
WO/2021/160654A1 |
This invention concerns a versatile and simple one-pot method to prepare nanomaterials, and in particular nanoparticles, grafted with an ultra-thin layer of calixarenes by placing at 5 least one oxidized metal with at least one calix[n]a...
|
|
WO/2021/162057A1 |
This organic electroluminescent element (1) includes at least two light emitting units (11, 12) arranged between an anode (3) and a cathode (4), and a first cathode-side organic layer (21), wherein: the first cathode-side organic layer (...
|
|
WO/2021/163355A1 |
Provided is a method of treatment of a sphingosine 1-phosphate subtype 1 (S1P1) receptor-associated disorder comprising: administering to an individual in need thereof a therapeutically effective amount of (R)-2-(7-(4-cyclopentyl-3-(trif...
|
